Value of PD-L1, PD-1, and CTLA-4 Expression in the Clinical Practice as Predictors of Response to Nivolumab and Ipilimumab in Monotherapy in Patients With Advanced Stage Melanoma

1. Santos-Briz, A.
2. Cañueto, J.
3. Carmen, S.D.
4. Barrios, B.
5. Yuste, M.
6. Bellido, L.
7. Ludeña, M.D.
8. Román, C.